Biopharma Deploying Trump Windfall to Buy Back Billions in Stock

(Bloomberg) -- Drugmakers, whose industry pricing faced renewed scorn this month from President Donald Trump, have been taking advantage of the U.S. tax overhaul he signed last year to buy back sha...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.